Glioblastoma pathology — SCE Neurology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Oligodendroglioma, IDH-mutant and 1p/19q-codeleted
The best answer is “Oligodendroglioma, IDH-mutant and 1p/19q-codeleted”. In an adult diffuse astrocytic glioma, IDH-wildtype status with necrosis or microvascular proliferation supports glioblastoma grade 4; integrated molecular diagnosis avoids the obsolete assumption that all infiltrating astrocytomas form one pathway. “Diffuse midline glioma, H3 K27-altered” is less appropriate because oligodendroglioma requires an IDH mutation as well as whole-arm 1p/19q codeletion “Glioblastoma, IDH-wildtype, CNS WHO grade 4” is less appropriate because the H3-altered entity requires its defining molecular change and appropriate anatomical context “Glioblastoma, IDH-wildtype, CNS WHO grade 4” is less appropriate because pilocytic astrocytoma is a biologically distinct circumscribed tumour “Meningioma, CNS WHO grade 2” is less appropriate because meningioma is not reclassified as a diffuse glial neoplasm by these findings
Reference: NICE NG99: Brain tumours and brain metastases in adults. https://www.nice.org.uk/guidance/ng99/chapter/Recommendations